LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crustacean antimicrobial peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Cryptic peptides and method for their identification

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Cryptophycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Cryptophycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Cryptophycins from synthesis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystal suspensions of insulin derivatives, processes for their

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystalline form of a drug

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystalline forms

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystalline forms

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystalline r-h-GM-CSF and method

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallizable compositions comprising a hepatitis C virus NS3 p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl est

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallization of a GLP-1 analogue

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallization of IGF-1

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallized recombinant human growth factor formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystallized structure of type IV collagen NC1 domain hexamer

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystals of etanercept and methods of making thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystals of the large ribosomal subunit

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Crystals of the large ribosomal subunit